Motoki Susa

Motoki Susa

Speaker
President, Lilac pharma Inc.

We have proposed a new idea of mRNA vaccine preparation that solves the vaccine's instability problem. The idea of "on-site preparation" using an appropriate microfluidic device enables us to provide effective mRNA vaccine to a person timely and globally without any cold chain equipment. We have strength of developing the microfluidic device and we are now seeking for partners (biotech company, academic institution, investor, etc.) who can implement the idea together.
Learn
Articles